3Pittiruti M, Hamilton H, Biffi R, et al. ESPEN guidelines on parenteral nutrition: central venous catheters ( access, care, diagnosis and therapy of complications) . Clin Nutr, 2009,28: 365-377.
4Chien LY, Maenab Y, Aziz K, et al. Variations in central venous catheter-related infection risks among Canadian neonatal intensive care units. Pediatr Infect Dis J, 2002,21:505-511.
5Inglis GD, Davies MW. Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical venous catheters. Cochrane Database Syst Rev,2005, 19 : CD005251.
6Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions. Version. 5. 1. 0. The Cochrane Collaboration, 2011. Available from www. cochrane- handbook, org.
7Spafford PS, Sinkin RA, Cox C, et al. Prevention of central venous catheter-related coagulase-negative staphylococcal sepsis in neonates. J Pediatr, 1994,125:259-263.
8Harms K, Herting E, Kron M, et al. Randomized, controlled trial of amoxicillin prophylaxis for prevention of catheter-related infections in newborn infants with central venous silicone elastomer catheters. J Pediatr, 1995, 127 : 615-619.
9Cooke RW, Nycyk JA, Okuonghuae H, et al. Low-dose vancomycin prophylaxis reduces coagulase-negative staphylococcal bacteraemia in very low birthweight infants. J Hosp Infect, 1997, 37:297-303.
10Garland JS, Alex CP, Henrickson K J, et al. A vancomycin- heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial. Pediatrics, 2005, 116 : e198-205.
